Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Change in Intangibles: 2021-2024

Historic Change in Intangibles for BridgeBio Pharma (BBIO) over the last 3 years, with Dec 2024 value amounting to $8.0 million.

  • BridgeBio Pharma's Change in Intangibles rose 50.47% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year change of. This contributed to the annual value of $8.0 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, BridgeBio Pharma's Change in Intangibles is $8.0 million, which was up 431.67% from $1.5 million recorded in FY2022.
  • In the past 5 years, BridgeBio Pharma's Change in Intangibles registered a high of $35.0 million during FY2021, and its lowest value of $1.5 million during FY2022.
  • Moreover, its 2-year median value for Change in Intangibles was $4.7 million (2022), whereas its average is $4.7 million.
  • Data for BridgeBio Pharma's Change in Intangibles shows a maximum YoY plummeted of 95.71% (in 2022) over the last 5 years.
  • BridgeBio Pharma's Change in Intangibles (Yearly) stood at $35.0 million in 2021, then slumped by 95.71% to $1.5 million in 2022, then reached $8.0 million in 2024.